JW Life Science acquires EU GMP for nutritional fluids for first time as Asian pharma

Published: 2018-04-05 16:32:49

Updated: 2018-04-05 16:32:49

JW acquired approval for EU-GMP of its nutritional fluid products for the first time as an Asian pharmaceutical company.

JW Life Science(CEO Sung-Nam Cha), a subsidiary of JW Holdings, announced on the 3^rd that the company acquired the European Union-Good Manufacturing Practice(EU-GMP) certificate for the chamber 3, a nutritional fluid manufacturing facilities in the JW Dangjin Factor, from th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.